Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Rockford
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Rockford, IL

Studies commonly pay $75 to $4,500 per completed study

113 clinical trials are currently recruiting participants within 30 miles of Rockford. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

113studies recruiting
7+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Rockford right now

Top 25 of 113 recruiting studies, sorted by proximity — each links to its official registry page

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation N/A Observational 20,000 participants sought
MercyHealth — Janesville, Wisconsin (29.3 mi) · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma Phase 2 Interventional 125 participants sought
Northwestern Medicine: Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Northwestern University

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Cutaneous Melanoma, Stage II N/A Interventional 2,998 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Melanoma and Skin Cancer Trials Limited

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Hepatocellular Carcinoma Phase 2 Interventional 200 participants sought
Northwestern Medicine Kishwaukee Hospital — DeKalb, Illinois (27.9 mi) · Sponsor: Northwestern University

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi) · Sponsor: SWOG Cancer Research Network

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Rectal Cancer Phase 3 Interventional 250 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Canadian Cancer Trials Group

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
OSF HealthCare_Cardiovasc Inst — Rockford, Illinois (1.7 mi) · Sponsor: Novo Nordisk A/S

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma Phase 3 Interventional 264 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma Phase 3 Interventional 398 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Phase 2 Interventional 156 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
Mercyhealth Cancer Institute - Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,500 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Phase 3 Interventional 1,978 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: NRG Oncology

Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)

Falls-Risk N/A Observational 30,000 participants sought
Swedish American Emergency Department — Rockford, Illinois (1.7 mi) · Sponsor: University of Wisconsin, Madison

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

Kidney Disease Phase 3 Interventional 347 participants sought
Panoramic Health - RNA of Rockford, LLC dba Rockford Nephrology Associates — Rockford, Illinois (1.7 mi) · Sponsor: Takeda

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Multiple conditions Phase 3 Interventional 158 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma Phase 2 Interventional 48 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near Rockford

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Rockford

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

UW Health | Carbone Cancer Center Rockford Laboratory

★ 4.8
3535 N Bell School Rd, Rockford, IL 61114
(779) 696-9400
"Friendly staff knowable staff all appointments right on time Dr Kahn took the time to answer all my questions"
— Fred Amundson, 5★

UW Health | Carbone Cancer Center Rockford

★ 4.7
3535 N Bell School Rd, Rockford, IL 61114
(779) 696-9400
"Nice and easy. On time. The two nurses were very experienced with very pleasant demeanor and helpful attitude."
— waleed said, 5★

Chicago Clinical Research Institute, Inc.

★ 5.0
611 W Roosevelt Rd, Chicago, IL 60607
(312) 823-6800

Innovative Clinical Research Center

★ 2.3
521 Kora Ln, Island Lake, IL 60042
"On March, 11 2024 I had a Urinary tract problem which they asked me to send results to a lab, and getting medication the same day, but that medicatio…"
— Jared Avitia, 1★

Avicenna Clinical Research

★ 4.9
9912 SW Hwy, Oak Lawn, IL 60453
(708) 575-5535
"Joy Jibunoh was very professional and knowledgeable!! Showed great patience when asking questions with clarity!"
— tony torres, 5★

New Life Clinical Research llc

★ 5.0
(847) 454-3872
"I am deeply grateful to Ekta Grewal for her incredible support throughout my journey in the NLCR program. Not only did she provide me with a partial …"
— Brianna Oppong-Antwi, 5★

Pillar Clinical Research, Chicago, Illinois

★ 4.8
3400 N Pulaski Rd, Chicago, IL 60641
(224) 534-7332
"All the staff of GREAT ADMINISTRATION THEY REALLY TAKE CARE OF THEIR PEOLE. AND I DO MEAN ALL. IT WAS A BEAUTIFUL EXPERIENCE. I WOULD DEFINITELY RECO…"
— Vig Dall, 5★

Clinical trials in Rockford: what's recruiting

The Rockford area currently has 113 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Rockford, the most active research areas are:

  • Cancer & Oncology20 studies
  • Liver & Kidney3 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Rockford, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Rockford

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Rockford participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Rockford?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Rockford safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Rockford, IL?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Rockford?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Rockford.

Paid clinical trials near Rockford

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IL

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts